Patents by Inventor Elisabet de los Pinos

Elisabet de los Pinos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Virus-like particle conjugates for diagnosis and treatment of tumors
    Patent number: 11806406
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Grant
    Filed: August 5, 2021
    Date of Patent: November 7, 2023
    Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
    Publication number: 20220387619
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: August 5, 2021
    Publication date: December 8, 2022
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Serv.
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • TARGETED COMBINATION THERAPY
    Publication number: 20220152217
    Abstract: Some embodiments of the present disclosure are directed to methods and compositions for the treatment of tumors, using a combination of immunotherapeutic agents and tumor-targeting viral capsid protein assemblages comprising anti-cancer molecules conjugated to viral capsid proteins.
    Type: Application
    Filed: April 11, 2018
    Publication date: May 19, 2022
    Applicants: Aura Biosciences, Inc., The USA, as Represented by the Secretary, Department of Health and Human Service
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines
  • VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
    Publication number: 20220088216
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: December 2, 2021
    Publication date: March 24, 2022
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
    Publication number: 20210393797
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: August 5, 2021
    Publication date: December 23, 2021
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • TARGETED COMBINATION THERAPY
    Publication number: 20210290778
    Abstract: Some embodiments of the present disclosure are directed to methods and compositions for the treatment of tumors, using a combination of immunotherapeutic agents and tumor-targeting viral capsid protein assemblages comprising anti-cancer molecules conjugated to viral capsid proteins.
    Type: Application
    Filed: April 11, 2018
    Publication date: September 23, 2021
    Applicants: Aura Biosciences, Inc., The USA, as Represented by the Secretary, Department of Health and Human Service
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines
  • Virus-like particle conjugates for diagnosis and treatment of tumors
    Patent number: 11110181
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: September 7, 2021
    Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • HPV particles and uses thereof
    Patent number: 10688172
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: June 23, 2020
    Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale), Aura Biosciences, Inc.
    Inventors: Pierre L. Coursaget, Antoine A. Touźe, Maxime J. J. Fleury, Nicolas Combelas, Elisabet de los Pinos
  • VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
    Publication number: 20200188529
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: January 31, 2020
    Publication date: June 18, 2020
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
    Patent number: 10596275
    Abstract: The invention relates to methods for producing papilloma-derived nanosphere particles that contain therapeutic, diagnostic, or other agents. The invention also provides nanosphere particle preparations that are useful for selectively delivering therapeutic, diagnostic, and/or other agents to cancer cells of subjects without eliciting a serotype-specific immunogenic response in the subjects.
    Type: Grant
    Filed: April 5, 2019
    Date of Patent: March 24, 2020
    Assignee: Aura Biosciences, Inc.
    Inventors: Elisabet de los Pinos, Rhonda C. Kines
  • Virus-like particle conjugates for diagnosis and treatment of tumors
    Patent number: 10588984
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: March 17, 2020
    Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • VIRION-DERIVED NANOSPHERES FOR SELECTIVE DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS TO CANCER CELLS
    Publication number: 20190275176
    Abstract: The invention relates to methods for producing papilloma-derived nanosphere particles that contain therapeutic, diagnostic, or other agents. The invention also provides nanosphere particle preparations that are useful for selectively delivering therapeutic, diagnostic, and/or other agents to cancer cells of subjects without eliciting a serotype-specific immunogenic response in the subjects.
    Type: Application
    Filed: April 5, 2019
    Publication date: September 12, 2019
    Applicant: Aura Biosciences, Inc.
    Inventors: Elisabet de los Pinos, Rhonda C. Kines
  • Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
    Patent number: 10300150
    Abstract: The invention relates to methods for producing papilloma-derived nanosphere particles that contain therapeutic, diagnostic, or other agents. The invention also provides nanosphere particle preparations that are useful for selectively delivering therapeutic, diagnostic, and/or other agents to cancer cells of subjects without eliciting a serotype-specific immunogenic response in the subjects.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: May 28, 2019
    Assignee: Aura Biosciences, Inc.
    Inventors: Elisabet de los Pinos, Rhonda C. Kines
  • HPV PARTICLES AND USES THEREOF
    Publication number: 20190142925
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Application
    Filed: November 29, 2018
    Publication date: May 16, 2019
    Applicants: INSERM (Institut National de la Santé et de la Recherche Médicale), Aura Biosciences, Inc.
    Inventors: Pierre L. Coursaget, Antoine A. Touzé, Maxime J.J. Fleury, Nicolas Combelas, Elisabet de los Pinos
  • VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
    Publication number: 20190083647
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: September 26, 2018
    Publication date: March 21, 2019
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Ser.
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • HPV particles and uses thereof
    Patent number: 10179168
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: January 15, 2019
    Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale, Aura Biosciences, Inc.
    Inventors: Pierre L. Coursaget, Antoine A. Touzé, Maxime J. J. Fleury, Nicolas Combelas, Elisabet de los Pinos
  • Virus-like particle conjugates for diagnosis and treatment of tumors
    Patent number: 10117947
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: November 6, 2018
    Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • VIRION-DERIVED NANOSPHERES FOR SELECTIVE DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS TO CANCER CELLS
    Publication number: 20180110883
    Abstract: The invention relates to methods for producing papilloma-derived nanosphere particles that contain therapeutic, diagnostic, or other agents. The invention also provides nanosphere particle preparations that are useful for selectively delivering therapeutic, diagnostic, and/or other agents to cancer cells of subjects without eliciting a serotype-specific immunogenic response in the subjects.
    Type: Application
    Filed: November 28, 2017
    Publication date: April 26, 2018
    Applicant: Aura Biosciences, Inc.
    Inventors: Elisabet de los Pinos, Rhonda C. Kines
  • Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
    Patent number: 9855347
    Abstract: The invention relates to methods for producing papilloma-derived nanosphere particles that contain therapeutic, diagnostic, or other agents. The invention also provides nanosphere particle preparations that are useful for selectively delivering therapeutic, diagnostic, and/or other agents to cancer cells of subjects without eliciting a serotype-specific immunogenic response in the subjects.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: January 2, 2018
    Assignee: Aura Biosciences, Inc.
    Inventors: Elisabet de los Pinos, Rhonda C. Kines
  • HPV PARTICLES AND USES THEREOF
    Publication number: 20170368162
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Application
    Filed: June 28, 2017
    Publication date: December 28, 2017
    Applicants: INSERM (Institut National de la Sante et de la Recherche Medicale), Aura Biosciences, Inc.
    Inventors: Pierre L. Coursaget, Antoine A. Touze, Maxime J.J. Fleury, Nicolas Combelas, Elisabet de los Pinos